Chennai, India May 2023: Annalise.ai, one of the world’s largest artificial intelligence (AI) radiology companies, has today announced it is continuing its global expansion with the opening of the Annalise India Centre in Chennai — Annalise’s first establishment in India.
The expansion into India continues Annalise.ai's fast-paced growth trajectory as it continues to increase its visibility and capabilities in new markets like the USA, UK, Europe, and Asia. The Annalise India Centre will become a part of this international network and concentrate on the development and marketing of new products. Annalise.ai combines superior imaging data with the very best in computer science to produce comprehensive AI clinical decision support solutions, empowering clinicians to make accurate, faster decisions.
According to Lakshmi Gudapakkam, CEO of Annalise.ai - “It makes perfect sense for Annalise.ai to have a presence in what is rapidly developing as a prominent medical device region. India is one of the fastest growing medical device markets globally and represents a very exciting opportunity," He added, “This is also a chance to make use of the diverse talent pool that makes India a technological hub and accelerate development of new AI applications.”
Annalise.ai currently plans to hire across product development including software engineers, product managers and regulatory, as well as to expand the commercial and business services teams.
The two flagship products in the Annalise product line are Annalise Enterprise CTB, one of the most complete AI decision support solutions available for non-contrast CT brain studies, and Annalise Enterprise CXR, one of the most comprehensive AI clinical decision-support solutions available for chest x-rays. These solutions are clinical assisting tools that employ deep learning algorithms to detect the possible existence of up to 124 chest x-ray results and up to 130 brain CT scan findings, including a wide spectrum of disorders that call for immediate intervention. The usage of Annalise.ai by radiologists as an assistance tool has been demonstrated to improve detection accuracy and gives clinicians access to a second pair of eyes. Annalise.ai has researched and deployed its AI technology across hundreds of leading hospitals and research clinics in Australia, the United Kingdom, the United States and Asia. These deployments have shown the improvement of diagnostic accuracy across patient populations in every country.
